comparemela.com

Latest Breaking News On - Biotech and pharma - Page 25 : comparemela.com

Eli Lilly s Mounjaro Outperforms Novo Nordisk s Ozempic: New Study

It's the latest indication that Mounjaro is more effective than Ozempic for weight loss.

United statesLilly mounjaroNovo ozempicEli lillyJosh nathan kazisNovo nordiskGetty imagesWhile ozempicWhile wegovyArticle normalHealthcare life sciencesNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testing

Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors

OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.

Nima farzanJames tananbaumKinnate biopharmaMadrigal pharmaceuticalsTemasek holdingsExchange commissionMed advisorsOrbimed advisorsForesite capitalAnderson investmentsArticle normalBiotechnology servicesFinancial investment servicesInvestment advice research servicesHealthcare life sciencesFinancial services

Vaccines: A Golden Age of Shots Is Here What It Means for You

Pharamaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.

United statesOnyema ogbuaguPhil dormitzerKawsar talaatStephen hogeJohns hopkinsJanssen covidSarina finkelstein barronNeal templinAnnaliesa andersonWorld health organizationCenters for diseaseWorld health associationCollege of wisconsinYale medical schoolDrug administration

Why the Cheapest Stock in the S&P 500 Is No Bargain

Viatris is the old generic drug company Mylan, acquired by Pfizer and merged with its Upjohn division. The stock has been falling ever since the deal closed.

United statesBerkshire hathawayJennifer anistonWarren buffettHeather breschIggy popTeva pharmaceutical industriesGood stuff coUnited airlines holdingsUnwanted coSynchrony financialWall streetGeneral motorsReverse morris trustJack houghArticle normal

Vertex Shares Dip on Anxiety Over Pain Pill Trial

Vertex's COO said a trial of its new pain pill hadn't tested the drug against a placebo.

David risingerJosh nathan kazisStuart arbuckleMichael yeeVertex pharmaceuticalsLeerink partnersArticle normalScientific research servicesHealthcare life sciencesBusiness consumer servicesMedical research servicesDrug discovery developmentHealthcare support servicesDiagnostic medical research servicesFinancial performanceShare price movement disruptions

vimarsana © 2020. All Rights Reserved.